Palatin WKN: A3DTUW ISIN: US6960775020 Kürzel: PTN Forum: Aktien User: allesaufaurora

Busch*e

3x +10% in einer Woche. Na ob da was im Busche ist.... ?

Kurzes Zucken hier wieder bei PLT ?

Bei mir dauert es auch noch bis zum EK… aber vielleicht erweckt diese Aktie ja noch einmal… sollte nun langsam wieder Berg auf gehen…

Ek 26€ ......😳

Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap. Aldeyra will receive a non-refundable option fee of $1 million and an upfront payment of $100 million less option fees if AbbVie chooses to exercise the option. Under the terms of the license agreement, Aldeyra would be eligible to receive up to $300 million in regulatory and commercial milestone payments, inclusive of a $100 million milestone payment upon U.S. Food and Drug Administration approval of reproxalap in dry eye disease; I hope this is not disadvantageous for PTN.

Wie eine Rakete die dauernd zündet, aber (noch) nicht abhebt. Ich bleib mit meinem EK von jenseits 20 Euro an Bord 😅

So ein dämlicher Zeitpunkt auch.

Unglaublich....

Und: zack, Verwässerung nach Kursanstieg durch Offering und sofort Kursverlust. Dauert dann noch länger alles...

PTN announced direct offering of 2.358M common shares at $2.12 per share for gross proceeds of $5M. The company has also agreed to issue in a private placement warrants to purchase up to an aggregate of 2.358M common shares at an exercise price of $2.12 per share.

Das wird erst noch anlaufen das Comeback.

läuft sehr gut heute

Zahlen sind nach ersten Erkenntnissen richtig top

Was bedeutet das: "Palatin Receives Notice of Non-Compliance from NYSE American"? PTN verfügt über mehr als 11 Millionen Aktien. Zum aktuellen Preis sind es mehr als 4 Millionen US-Dollar. Ich verstehe das nicht (requires a listed company to have stockholders' equity of $4 million or more). Weiß jemand Bescheid?

Palatin Receives Notice of Non-Compliance from NYSE American. Section 1003(a)(i) requires a listed company to have stockholders' equity $2 million or more if the listed company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, and Section 1003(a)(ii) requires a listed company to have stockholders' equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. Palatin is now subject to the procedures and requirements of Section 1009 of the NYSE American Company Guide. Palatin has until November 9, 2023, to submit a plan (the "Plan") of actions it has taken or will take to regain compliance with the continued listing standards by April 10, 2025.